Home/Filings/4/0001827584-25-000003
4//SEC Filing

Neervannan Seshadri 4

Accession 0001827584-25-000003

CIK 0001819790other

Filed

Dec 17, 7:00 PM ET

Accepted

Dec 18, 4:09 PM ET

Size

6.7 KB

Accession

0001827584-25-000003

Insider Transaction Report

Form 4
Period: 2025-12-16
Neervannan Seshadri
Chief Operating Officer
Transactions
  • Gift

    Common Stock

    2025-12-1695079,183 total
  • Gift

    Common Stock

    2025-12-16+475475 total(indirect: By daughter)
Footnotes (2)
  • [F1]Includes 451 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2025.
  • [F2]This transaction involved the Reporting Person's gift of 475 shares of common stock to his daughter who shares Reporting Person's household. The Reporting Person disclaims beneficial ownership of the securities held by his daughter, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

Issuer

Tarsus Pharmaceuticals, Inc.

CIK 0001819790

Entity typeother

Related Parties

1
  • filerCIK 0001827584

Filing Metadata

Form type
4
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 4:09 PM ET
Size
6.7 KB